Novel Therapeutic Targets in Myocardial Infarction
Symposium - New York, United States
Myocardial infarction (MI) is a leading cause of death worldwide. 20 million people die from cardiovascular disease each year and patients that survive are at high risk of a recurrent MI and heart failure. Although there are treatments to mitigate the initial cardiac damage during an acute myocardial infarction, there is a need for novel treatments to minimize subsequent cardiac remodeling that can adversely affect heart function. In this context, identifying new targets to improve tissue repair—including preservation of the cardiac microvasculature, clearance of apoptotic cells and tissue regeneration- might become of great interest to improve cardiac remodeling and function after MI. This symposium brings together leading experts in the field to discuss the best strategy to prevent microvascular damage and improve tissue regeneration after MI.
(Courtesy of New York. From Wikipedia, en.wikipedia.org)
Novel Therapeutic Targets in Myocardial Infarction
Fri, Dec 14, 2012 - Fri, Dec 14, 2012 | 8:00 AM - 4:00 PM
The New York Academy of Sciences
250 Greenwich Street, 40th Fl, New York, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
